Health Care/Hospital
Frost & Sullivan Publishes Annual Update on Brainsway
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 17:57
857
Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201
TAICANG, China, May 6, 2019 /PRNewswire/ -- Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody, CBP-201. The randomized, double-blind, placebo-controlled study, conducted inMelbourne, Australia, evaluated t...
2019-05-06 17:00
881
Scientific Advisory Board Announced for DELopen to Guide the Open Access DNA Encoded Library Interchange
SHANGHAI and BOSTON, May 6, 2019 /PRNewswire/ -- DELopen, a new platform dedicated to the hit generation of drug discovery of DNA Encoded Library (DEL) Technology, has announced the formation of its Scientific Advisory Board. The board, chaired by Dr. Richard Lerner, Institute Professor of Scripp...
2019-05-06 13:38
1426
Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, May 6, 2019 /PRNewswire/ -- Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. (CTTQ) today announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics for multiple thera...
2019-05-06 10:49
1763
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
SHANGHAI and SAN DIEGO, May 5, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired Pharmapace, Inc., a US-based clinical research services company with expertise of provid...
2019-05-06 07:50
2561
Darren Birkelbach Appointed President Of American International Chemical, LLC
NORWALK, Connecticut, May 4, 2019 /PRNewswire/ -- Charles Hinnant, CEO of LBB Specialties LLC, announced that effectiveMay 15, Darren J. Birkelbach will become President of American International Chemical, LLC ("AIC"), a subsidiary of LBB Specialties. Mr. Birkelbach joins AIC after a successful ...
2019-05-04 00:30
1725
Frost & Sullivan Webinar to Present the Top 50 Disruptive Technologies & Growth Opportunities Transforming Our World
Multi-billion Dollar Technologies Ready to Energize and Impact the Future for Multiple Industries LONDON, May 3, 2019 /PRNewswire/ -- Frost & Sullivan, the growth partnership company, announced today the release of theTop 50 Emerging Technologies and Growth Opportunities, a comprehensive analysi...
2019-05-03 00:16
1731
Medical Korea Seek to Spread "Medical Korean Wave" in Vietnam
SEOUL, South Korea and HANOI, Vietnam, May 2, 2019 /PRNewswire/ -- Starting May 8 (Wednesday), Korea Health Industry Development Institute(KHIDI) will operate the "Medical Korea Zone" for four days at the 6th Vietnam International Medical Tourism Exhibition (Vietnam Medical Tourism 2019) at Frien...
2019-05-02 16:44
2902
Ping An Good Doctor's Omni-channel User Traffic Hits 55 Million
HONG KONG, May 2, 2019 /PRNewswire/ -- According to Trustdata, China's leading internet big data monitoring platform,Ping An Good Doctor's (01833.HK) omni -channel user traffic achieved 55 million as the end of the first quarter of 2019, representing a year-on-year increase of 180%. The datawas re...
2019-05-02 16:01
8319
Ortoma Engages M&A Advisor
STOCKHOLM, May 2, 2019 /PRNewswire/ -- Ortoma and the Board of Directors have engaged MedWorld Advisors (www.medworldadvisors.com ) as M&A advisor to assist the company and the Board with management, evaluations, and negotiations in connection with any M&A transaction. During the past year, the ...
2019-05-02 15:32
5587
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
TAMPA, Fla., May 2, 2019 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) forMagicTouch, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of coronary in-stent restenosis (ISR). In-ste...
2019-05-02 15:00
1792
CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
SUZHOU, China and ZURICH, May 2, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) and Numab Therapeutics AG ("Numab") today announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a potential best-in-clas...
2019-05-02 11:05
3606
Beckman Coulter Introduces Total Laboratory Automation Solution That Sets New Standard for Turnaround Time
The DxA 5000 delivers rapid and consistent turnaround time, provides the industry's most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif., May 2, 2019 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today...
2019-05-02 08:00
2669
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments SUNNYVALE, California, May 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with...
2019-05-02 04:10
6163
binx health Receives CE Mark For Rapid Chlamydia And Gonorrhea Test For Mass Markets
Multiplex Test Panel for binx io® Point-of-Care Platform Positioned to Radically Reduce Time to Treatment, Expand Access to Care BOSTON, May 2, 2019 /PRNewswire/ -- binx health™, the pioneer in anywhere care today announced that its proprietary Chlamydia and Gonorrhea (CT/NG) test has received E...
2019-05-02 03:11
2230
DrFirst Earns Acclaim from Frost & Sullivan for its Highly Secure, Patient-centric Communication Solution for the Care Collaboration Market
DrFirst Backline™ ensures that care team members are equipped with seamless, efficient, real-time communication tools around the clock at any point-of-care SANTA CLARA, California, May 2, 2019 /PRNewswire/ -- Based on its recent analysis of the North American market for secure text messaging for ...
2019-05-02 02:51
1157
3-V Biosciences Commences Dosing in Phase 2 Clinical Study of the FASN Inhibitor TVB-2640 in Patients with NASH
SAN MATEO, Calif. and HANGZHOU and SHAOXING, China, May 1, 2019 /PRNewswire/ -- 3-V Biosciences, Inc. (3-V Biosciences) and Ascletis Pharma Inc. (Ascletis, 1672.HK)announced that 3-V Biosciences has recently dosed its first patient in a Phase 2 clinical trial of the FASN (fatty acid synthase) inh...
2019-05-01 06:00
5857
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
MADISON, Wisconsin, April 30, 2019 /PRNewswire/ -- Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG; OTCQX: RHHBY) to commercialize its proprietary chemical synthesis technology for drug discovery and development. The comp...
2019-04-30 22:00
7849
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
* Preclinical, 'proof-of-concept' results for a novel 'all-in-one' immunotherapy for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-positive solid tumors * The preclinical findings support the advancement of this multimodal immunotherapy into a Phase I clinical trial SINGAPO...
2019-04-30 22:00
2385
Australia's First Commercial MGISEQ-2000 Genetic Sequencer Now in Operation
MELBOURNE, Australia, April 30, 2019 /PRNewswire/ -- MGI
2019-04-30 21:30
4822
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7859
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6954
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
5072
